Evidence for the involvement of the adenosine A2A receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine
- 31 July 2008
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 55 (1), 35-40
- https://doi.org/10.1016/j.neuropharm.2008.04.007
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Adenosine-Based Cell Therapy Approaches for Pharmacoresistant EpilepsiesNeurodegenerative Diseases, 2007
- Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockadePurinergic Signalling, 2005
- Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicityBritish Journal of Pharmacology, 2003
- Functional striatal hypodopaminergic activity in mice lacking adenosine A2A receptorsJournal of Neurochemistry, 2001
- Regulation of the Ecto-Nucleotidase Pathway in Rat Hippocampal Nerve TerminalsNeurochemical Research, 2001
- A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in MiceJournal of Neuroscience, 1999
- Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 miceEuropean Journal of Pharmacology, 1999
- Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampusNeuroscience Letters, 1995
- Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophyllinePharmacology Biochemistry and Behavior, 1990
- Purinergic mechanisms in epilepsyProgress in Neurobiology, 1988